Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 2016;131(6):803-20.
Anan M, Ishii M, Nakamura T, et al. Postoperative adjuvant treatment for pineal parenchymal tumour of intermediate differentiation. J Clin Neurosci 2006;13:965-8.
Lutterbach J, Fauchon F, Schild SE, et al. Malignant pineal parenchymal tumors in adult patients: patterns of care and prognostic factors. Neurosurgery 2002;51(1):44-55.
Schild SE, Scheithauer BW, Schomberg PJ, et al. Pineal parenchymal tumors. Clinical, pathologic, and therapeutic aspects. Cancer 1993;72(3):870-80
Schild SE, Scheithauer BW, Haddock MG, et al. Histologically confirmed pineal tumors and other germ cell tumors of the brain. Cancer 1996;15;78(12):2564-71.
Mallick S, Benson R, Rath GK. Patterns of care and survival outcomes in patients with pineal parenchymal tumor of intermediate differentiation: An individual patient data analysis. Radiother Oncol 2016;121(2):204-08.
Das P, Mckinstry S, Devadass A, et al. Are we over treating pineal parenchymal tumour with intermediate differentiation? Assessing the role of localised radiation therapy and literature review. Springerplus 2016;5:26.
Niyazi M, Brada M, Chalmers AJ, et al. ESTRO-ACROP guideline “target delineation of glioblastomas”. Radiother Oncol 2016;118(1):35-42.
Watanabe T, Mizowaki T, Arakawa Y, et al. Pineal parenchymal tumor of intermediate differentiation: Treatment outcomes of five cases. Mol Clin Oncol 2014;2(2):197-202.
Yi J, Kim H, Choi Y, et al. Successful treatment by chemotherapy of pineal parenchymal tumor with intermediate differentiation: a case report. Cancer Res Treat 2013;45(3): 244-9.
Raleigh DR, Solomon DA, Lloyd SA, et al. Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome. Neuro Oncol 2017;19(1): 78-88.
